A A A
-->

Publikationen

 

2013:

Brualla L, Sempau J, Zaragoza FJ, Wittig A, Sauerwein W:
Accurate estimation of dose distributions inside an eye irradiated with Ru-106
plaques.
Strahlenther Onkol. 2013 Jan;189(1):68-73.

Czarnecki D, Zink K
Small field photon dosimetry
accepted for publication in Phys. Med. Biol. (2013)

 

2012:

Roelofs E, Engelsman M, Rasch C, Persoon L, Qamhiyeh S, de Ruysscher D,
Verhaegen F, Pijls-Johannesma M, Lambin P; ROCOCO Consortium.
Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.
J Thorac Oncol. 2012 Jan;7(1):165-76.
IF: 3.661

Bert C, Engenhart-Cabillic R, Durante M:
Particle therapy for noncancer diseases.
Med. Phys. 2012 Apr;39(4): 1716-27
IF: 3.095

Lohr F, Baus W, Vorwerk H, Schlömp B, André L, Georg D, Hodapp N:
Rules and regulations applying to incidents in radiotherapy.
(AG Patientensicherheit der DEGRO/DGMP/VMTRO sowie für die ÖGRO/ÖGMP
and SASRO/SGSMP.
Strahlenther Onkol. 2012 Jul;188(7):545-50.
IF: 3.561

Czarnecki D, Wulff J, Zink K:
The influence of linac spot size on scatter factors.
Metrologia 49 (2012) Aug;S215–S218
IF: 1.750

Jelen U, Ammazzalorso F, Chanrion M-A, Gräf S, Zink K, Engenhart-Cabillic R, Wittig A:
Robustness against interfraction prostate movement in scanned ion beam radiation
therapy.
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e257-62.
IF: 4.503

Grün R, Friedrich T, Elsässer T, Krämer M, Zink K, Karger C, Durante M,
Engenhart-Cabillic R, Scholz M:
Impact of enhancements in the Local Effect Model (LEM) on the predicted RBE
weighted target dose distribution in carbon ion therapy.
Phys Med Biol. 2012 Nov 21;57(22):7261-74.
IF: 2.829

Fokas E, Henzel M, Surber G, Kleinert G, Hamm K, Engenhart-Cabillic R:
Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases
J Neurooncol. 2012 Apr 15 [Epub ahead of print]
IF: 3.214

Combs SE, Kieser M, Habermehl D, Weitz J, Jäger D, Fossati P, Orrechia R,
Engenhart-Cabillic R, Pötter R, Djosanjh M, Jäkel O, Büchler M W, Debus J:
Phase I/II Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Recurrent
Rectal Cancer: The PANDORA-01 Trial.
BMC Cancer. 2012 Apr 3;12:137. doi. 10.1186/1471-2407-12-137.
IF: 3.011

Sauerwein W, Engenhart-Cabillic R, Forman JD, Gueulette J, Hachem S, Jones D, Krüll A,
Lukas P, Mandrillon P, Petry W, Rosenberg I, Fert FV, Welsh, JS:
Neutron radiotherapy in South Africa: neutron radiotherapy should continue.
S Afr Med J. 2012 Mar 23;102(5):269-70; author reply 270-1.

Brualla L, Zaragoza FJ, Sempau J, Wittig A, Sauerwein W:
Electron irradiation of conjunctival lymphoma – Monte Carlo simulation of the minute
dose distribution and technique optimization.
Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1330-7. Epub 2012 Jan 13.
IF: 4.503

Hattar K, Savai R, Subtil FSB, Wilhelm J, Schmall A, Lang DS, Goldmann T, Eul B,
Dahlem G, Fink L, Schermuly RT, Banat GA, Sibelius U, Grimminger F, Vollmer E,
Seeger W, Grandel U:
Endotoxin induces proliferation of NSCLC in vitro and in vivo – role of COX-2 and EGFR activation.
Cancer Immunol. Immunother. 2012 Aug 26 [Epub ahead of print].
IF: 3.701

Zabel-du Bois A, Milker-Zabel S, Henzel M, Popp W, Debus J, Sack H,
Engenhart-Cabillic R:
Evaluation of time, attendance of medical staff, and resources during stereotactic
radiotherapy/radiosurgery: QUIRO-DEGRO Trial.
Strahlenther Onkol 2012 Aug 188:769-776 DOI 10.1007/s00066-012-0140-1.
IF: 2.541

Zink K, Wulff J:
Beam quality corrections for parallel-plate ion chambers in electron reference
dosimetry.
Phys Med Biol. 57, 1831-1854.
IF: 2.829

Mäder U, Marquardt K, Beer S, Bergmann T, Schmidts T, Heverhagen J, Zink K, Runkel F,
Fiebich M:
Evaluation and quantification of spectral information in tissue by confocal
microscopy.
J Biomed Optics 2012 Oct 17: 106011.
IF: 3.157

Anton M, Kapsch R P, Krauss M, von Voigts-Rhetz P, Zink K, McEwen M
Investigating the difference in the relative response of the alanine dosimeter to megavoltage x-ray and electron beams
submitted to Phys. Med. Biol. (2012)

 

2011:

Kamlah F, Hänze J, Seay U, Juricko J, Hasan D, Bischoff B, Arenz A, Fournier C,
Taucher-Scholz, G, Scholz M, Seeger W, Engenhart-Cabillic R, Rose F:
Comparison of the effects of carbon ion and photon irradiation on the angiogentic
response in human lung adenocarcinoma cells.
Int J Radiat Oncology Biol Phys 2011 Aug 1;80(5):1541-9. Epub 2011 May 27.
IF: 4.503

Fokas E, An Y, Juricko J, Engenhart-Cabillic R, An H:
Genetic alterations after carbon ion irradiation in human lung adenocarcinoma cells.
Int J Oncol. 2011 Jan;38(1):161-8.
IF: 2.391

Zink K, Wulff J:
On the wall perturbation correction for a parallel-plate NACP-02 chamber in clinical electron beams.
Med Phys. 2011 Feb;38(2):1045-54.
IF: 3.095

Roth J, Engenhart-Cabillic R, Eberhardt L, Timmesfeld N, Strassmann G:
Preoxygenated hyperventilated hypocapnic apnea-induced radiation (PHAIR) in breast
cancer patients.
Radiother Oncol. 2011 Aug;100(2):231-5. Epub 2011 Apr 16.
IF: 4.329

Wittig A, Engenhart-Cabillic R:
Cardiac side-effects of conventional and particle radiotherapy in cancer patients.
Herz. 2011 Jun;36(4):311-324.
IF: 0.712

You A, Fokas E, Wang LF, He H, Kleb B, Niederacher D, Engenhart-Cabillic R, An HX:
Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial
ovarian cancer.
J Cancer Res Clin Oncol. 2011 Apr;137(4):621-7. Epub 2010 Jun 9.
IF: 2.423

Sterzing F, Engenhart-Cabillic R, Flentje M, Debus J:
Image-guided radiotherapy: a new dimension in radiation oncology.
Dtsch Arztebl Int. 2011 Apr;108(16):274-80. Epub 2011 Apr 22.
IF: 2.108

Fokas E, Henzel M, Hamm K, Surber G, Kleinert G, Engenhart-Cabillic R:
Multidisciplinary treatment of brain metastases derived from colorectal cancer
incorporating stereotactic radiosurgery: analysis of 78 patients.
Clin Colorectal Cancer. 2011 Jun;10(2):121-5. Epub 2011 Apr. 22.
IF: 1.735

Strassmann G, Olbert P, Hegele A, Richter D, Fokas E, Timmesfeld N, Hofmann R,
Engenhart-Cabillic R:
Advantage of robotic needle placement on a prostate model in HDR brachytherapy.
Strahlenther Onkol. 2011 Jun;187(6):367-72. Epub 2011 May 17.
IF: 2.541

Gu X, Jelen U, Li J, Jia X, Jiang SB:
A GPU-based finite-size pencil beam algorithm with 3D-density correction for
radiotherapy dose calculation.
Phys Med Biol. 2011 Jun 7;56(11):3337-50.
IF: 3.056

Vorwerk H, Hess CF:
Guidelines for delineation of lymphatic clinical target volumes for high conformal
radiotherapy: head and neck region.
Radiat Oncol. 2011 Aug 19;6(1):97.

Wittig A, Sheu-Grabellus SY, Collette L, Moss R, Brualla L, Sauerwein W:
BPA uptake does not correlate with LAT1 and Ki67 expressions in tumor samples
(results of EORTC trial 11001).
Appl Radiat Isot. 2011 Dec;69(12):1807-12. Epub 2011 Feb 16.
IF: 1.094

Sauerwein W, Moss R, Stecher-Rasmussen F, Rassow J, Wittig A:
Quality management in BNCT at a nuclear research reactor.
Appl Radiat Isot. 2011 Dec;69(12):1786-9.
IF: 1.094

Wittig A, Stecher-Rasmussen F, Hilger RA, Rassow J, Mauri P, Sauerwein W:
Sodium mercaptoundecahydro-closo-dodecaborate (BSH), a boron carrier that merits more attention.
Appl Radiat Isot. 2011 Dec;69(12):1760-4. Epub 2011 Mar 21.
IF: 1.094

 

2010:

Fokas E, Henzel M, Hamm K, Surber G, Kleiner G, Engenhart-Cabillic R:
Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?
Strahlenther Onkol 2010: 186: 210-217.

Strassmann G, Abdellaoui S, Richter D, Bekkaoui F, Haderlein M, Fokas E, Timmesfeld N,
Vogel B, Henzel M, Engenhart-Cabillic R:
Atlas-based semiautomatic target volume definition (CTV) for head-and-neck tumors.
Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1270-6. Epub 2010 Jul 12.

Fokas E, Hänze J, Kamlah F, Eul BG, Lang N, Keil B, Heverhagen JT,
Engenhart-Cabillic R, An H, Rose F:
Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model.
Int J Radiat Oncology Biol Phys 2010, No 5, 1500-1508.

Reich E, Engenhart-Cabillic R, Rosenow F:
Strahlentherapie bei arteriovenösen Malformationen assoziierten Epilepsien.
Zeitschrift für Epileptologie 2. 2010. 238-242.

Fokas E, Kamlah F, Hänze J, Engenhart-Cabillic R, Rose F, An H:
EphA2 blockade enhances the antiendothelial effect of radiation and inhibits irradiated tumor cell-induced migration of endothelial cells.
Thoracic Cancer (2010) 10.1111/j. 1759-7714.2010. 2229x.

He H, Fokas E, You A, Engenhart-Cabillic R, An H:
Siah1 proteins enhance radiosensitivity of human breast cancer cells.
BMC Cancer 10: 403 (03. Aug. 2010).

Fokas E, Henzel M, Engenhart-Cabillic R:
A comparison of Radiotherapy with Radiotherapy plus Surgery for Brain Metastases from Urinary Bladder Cancer. Analysis of 62 Patients.
Strahlentherapie und Onkologie (2010) 186, 565-571.

Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Engenhart-Cabillic R, Fietkau R,
Feyer P, Haase W, Harms W, Rödel C, Soucon R, Wenz F, Sauer R:
Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer.
Strahlentherapie und Onkologie 2010; 186: 651-7.

Kuhn T, Sandner A, Wandt T, Engenhart-Cabillic R, Lammering G, Flentje M,
Grabenbauer G, Schreiber A, Pirnasch A, Dunst J:
Phase 1 trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck.
Annals of Oncology 21: 2284-2289, 2010.

Danova D, Kästner B, Wulff J, Fiebich M, Zink K, Klose K J, Keil B, Heverhagen J.
Reduction Of Uterus Dose In Clinical Thoracic Computed Tomography.
RöFo 182 (2010) 1091-1096

Wulff J, Heverhagen J T, Zink K, Kawrakow I
Investigation of systematic uncertainties in Monte Carlo calculated beam quality factors.
Phys. Med. Biol. 55 (2010) 4481-4493

Wulff J, Zink K
Investigation of correction factors for non-reference conditions in ion chamber photon dosimetry with Monte-Carlo simulations
Z. Med. Phys. 20 (2010) 25-33

Tertel J, Wulff J, Karle H, Zink K
Verification of a commercial implementation of the Macro Monte Carlo electron dose calculation algorithm using the virtual accelerator approach
Z. Med. Phys. 20 (2010) 51-60

 

2009:

Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, Langer P,
Engenhart-Cabillic R, Bitzer M, Königsrainer A, Budach W, Wilke H:
Phase III comparison of preoperative chemotherapy compared with
chemoradiotherapy in patients with locally advanced adenocarcinoma of the
esophagogastric junction.
J Clin Oncol. 2009 Feb 20;27(6):851-6. Epub 2009 Jan.12.

Kamlah F, Eul BG, Li S, Lang N, Marsh LM, Seeger W, Grimminger F, Rose F, Hänze J:
Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs
survival in a Lewis lung carcinoma cancer model.
Cancer Gene Ther. 2009 Mar;16(3): 195-205. Epub 2008 Sep 26.

Henzel M, Hamm K, Sitter H, Gross MW Surber G, Kleinert G, Engenhart-Cabillic R:
Comparison of stereotactic radiosurgery and fractionated stereotactic radiotherapy of
acoustic nerinomas according to 3-D tumor volume shrinkage and quality of life.
Strahlenther Onkol 2009, No 9, 567-573.

Fokas E, Kraft G, An H, Engenhart-Cabillic R:
Ion beam radiobiology and cancer:Time to update ourselves.
Biochim Biophys Acta 1796 (2009) 216-229.

Xia P, An H, Dang C, Radpour R, Kohler C, Fokas E, Engenhart-Cabillic R, Holzgreve W,
Zhong XY:
Decreased mitochondrial DNA content in blood samples of patients with stage I breast
cancer.
BMC Cancer 2009, 9: 454.

Fokas E, Wacker U, Gross MW, Henzel M, Encheva E, Engenhart-Cabillic R:
Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?
Strahlenther Onkol. 2009 Apr;185(4):235-40. Epub 2009 Apr 16.

Bremke M, Barth PJ, Sesterhenn AM, Budach V, Engenhart-Cabillic R, Werner JA:
Prospective study on neck dissection after primary chemoradiation therapy in stage IV
pharyngeal cancer.
Anticancer Res. 2009 Jul;29(7):2645-54.

Teymoortash A, Müller F, Juricko J, Bieker M, Mandic R, Librizzi D, Höffken H,
Pfestroff A, Werner JA:
Botulinum toxin prevents radiotherapy-induced salivary gland damage.
Oral Oncol. 2009 Aug;45(8):737-9. Epub 2009 Feb 11.

Scherf C, Peter C, Moog J, Licher J, Kara E, Zink K, Rödel C, Ramm U
Silicon diodes as an alternative to diamond detectors for depth dose curves and profile measurements of photon and electron radiation
Strahlenther Onkol 185 (2009) 530-536

Wulff J, Ubrich F, Zink K
Comment on "Monte Carlo simulation of an x-ray volume imaging cone beam CT unit"
Med. Phys. 36 (2009) 127-136

Zink K, Wulff J
Positioning of a plane-parallel ionization chamber in clinical electron beams and the impact on perturbation factors
Phys. Med. Biol. 54 (2009) 2421-2435

 

2008:

Hamm K, Henzel M, Gross MW, Surber G, Kleinert G, Engenhart-Cabillic R:
Radiosurgery/Stereotactic Radiotherapy in the therapeutical concept for skull base
meningiomas.
Zentralbl Neurochir 2008 Feb;69(1):14-21

Henzel M, Hamm K, Gross MW Surber G, Kleinert G, Failing T, Sitter H, Strassmann G,
Engenhart-Cabillic R:
Fractionated stereotactic radiotherapy of glomus jugulare tumors.
Strahlenther Onkol 2007; 183: 557-562.

Wang L-F, Fokas E, Bieker M, Rose F, Rexin P, Zhu Y, Pagenstecher A,
Engenhart-Cabillic R, An H:
Increased expression of EphA2 correlates with adverse outcome in primary and
recurrent glioblastoma multiforme patients.
Oncol Rep. 2008 Jan;19(1):151-6

Eich HT, Engenhart-Cabillic R, Hansemann K, Lukas P, Schneeweiss A,
Seegenschmiedt H, Skripnitchenko R, Staar S, Willich N, Müller RP:
Quality control of involves filed radiotherapy in patients with early-favorable (HD10)
and early-unfavorable (HD11) Hodgkin’s lymphoma – An analysis of the German
Hodgkin Study Group (GHSG)
Int J Radiat Oncol Biol Phys 2008 Aug 1,71(5):1419-24.

Eich HT; Müller RP, Engenhart-Cabillic R, Lukas P, Schmidberger H, Staar S, Willich N:
German Hodgkin Study Group. Involved-node radiotherapy in early-stage Hodgkin’s lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG).
Strahlenther Onkol. 2008 Aug; 184(8):406-10.

Sure U, Sürücu O, Engenhart-Cabillic R:
Embolization before radiosurgery reduces the obliteration rate of arteriovenous
malformations.
Neurosurgery 2008 Aug; 63(2): E376, author reply E376.

Hamm KD, Gross MW, Fahrig A, Surber G, Henzel M, Kleinert G, Grabenbauer G,
Engenhart-Cabillic R:
Stereotactic radiotherapy for the treatment of nonacoustic schwannomas.
Neurosurgery. 2008 May;62(5 Suppl):A29-36; discussion A36.

Hamm KD, Henzel M, Gross MW, Surber G, Kleinert G, Engenhart-Cabillic R:
Radiosurgery/stereotactic radiotherapy in the therapeutical concept for skull base
meningiomas.
Zentralbl Neurochir. 2008 Feb; 69(1):14-21.

Wang LF, Fokas E, Juricko J, You A, Rose F, Pagenstecher A, Engenhart-Cabillic R,
An HX:
Increased expression of EphA7 correlates with adverse outcome in primary and
recurrent glioblastoma multiforme patients.
BMC Cancer. 2008 Mar 25;8:79.